Kacew S, Narbaitz R
Drug Chem Toxicol. 1981;4(2):123-32. doi: 10.3109/01480548108998255.
Treatment of newborns with 20 mg/kg/day chlorphentermine orally for 1 week increased incorporation of thymidine into lung DNA without an associated change in tissue morphology or cyclic AMP levels. An increase in chlorphentermine dose to 60 mg/kg resulted in an accumulation of alveolar hypertrophic macrophages and a rise in incorporation of thymidine into lung DNA; however, cyclic AMP levels were decreased. In contrast, 20 or 60 mg/kg/day for 1 week phentermine-induced depression in the incorporation of thymidine into pulmonary DNA was accompanied by a decrease in cyclic AMP but no apparent alteration in tissue morphology. Hyperoxia did not modify the phentermine-induced changes in cyclic AMP levels and pulmonary ultrastructure. In contrast, hyperoxia altered the responsiveness of newborns to 20 mg/kg chlorphentermine as evidenced by the presence of foam cells. Data suggest that the chlorphentermine-induced increase in DNA synthesis in newborn lung seems independent of changes in cyclic AMP and tha modification of drug-induced alterations by hyperoxia may be related to the chemical structure of a compound.
对新生儿口服20毫克/千克/天的氯苯丁胺,持续1周,可增加胸腺嘧啶核苷掺入肺DNA的量,而组织形态或环磷酸腺苷水平无相关变化。将氯苯丁胺剂量增加至60毫克/千克,会导致肺泡肥大巨噬细胞积聚,并使胸腺嘧啶核苷掺入肺DNA的量增加;然而,环磷酸腺苷水平会降低。相比之下,1周内每天20或60毫克/千克的苯丁胺会导致胸腺嘧啶核苷掺入肺DNA的量减少,同时伴有环磷酸腺苷减少,但组织形态无明显改变。高氧并未改变苯丁胺引起的环磷酸腺苷水平和肺超微结构的变化。相反,高氧改变了新生儿对20毫克/千克氯苯丁胺的反应,表现为出现泡沫细胞。数据表明,氯苯丁胺引起的新生肺DNA合成增加似乎与环磷酸腺苷的变化无关,高氧对药物引起的改变的修饰可能与化合物的化学结构有关。